Among more than 25,000 men and women, those who were randomly assigned to take 2,000 international units (IU) of vitamin D each day for an average of 5.3 years were nearly 20% less likely than those who received a placebo to have an advanced cancer — defined here as one that metastasized (spread from the original tumor site) or proved fatal.
© Harvard university